Helen Ljungdahl Round
President and CEO
+46 73 077 02 83
+1 267 809 1225
Please enter your information in the form for general inquiries or to contact sales.
Additional contact information is listed below.
You may be able to find the information you need amongst the frequently asked questions.
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease (CAD) rule-out.
The CE-mark approved and FDA De Novo cleared Acarix CADScor®System is for patients experiencing stable chest pain with suspected CAD and is designed to help reduce millions of unnecessary and costly diagnostic procedures.2 CADScor®System calculates a patient-specific CAD-score non-invasively in 10 minutes with at least 96% confidence (Negative Predictive Value).¹
Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX).